Guidant Accepts Yet Another J&J Bid As Takeover War Escalates
This article was originally published in The Gray Sheet
Executive Summary
Guidant accepted an increased takeover bid by Johnson & Johnson late Jan. 13, leaving Boston Scientific to once again weigh whether to continue its bidding war with J&J